Archit Organosys Ltd
Incorporated in 1989, Archit Organosys Ltd
does manufacturing and trading of chemicals
and organics[1]
- Market Cap ₹ 77.8 Cr.
- Current Price ₹ 37.9
- High / Low ₹ 51.4 / 36.2
- Stock P/E 195
- Book Value ₹ 31.3
- Dividend Yield 1.32 %
- ROCE 3.60 %
- ROE 0.64 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of 11.0% over last 3 years.
- Earnings include an other income of Rs.5.70 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 19 | 21 | 138 | 128 | 113 | |
| 18 | 20 | 121 | 108 | 106 | |
| Operating Profit | 1 | 1 | 17 | 20 | 7 |
| OPM % | 4% | 4% | 12% | 15% | 6% |
| 0 | 1 | 2 | 3 | 6 | |
| Interest | 0 | 1 | 2 | 2 | 3 |
| Depreciation | 0 | 0 | 5 | 5 | 6 |
| Profit before tax | 0 | 1 | 11 | 15 | 4 |
| Tax % | 8% | 48% | 28% | 26% | 24% |
| 0 | 0 | 8 | 11 | 3 | |
| EPS in Rs | 0.39 | 0.41 | 4.01 | 5.53 | 1.60 |
| Dividend Payout % | 0% | 0% | 0% | 9% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -96% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 11% |
| 3 Years: | -18% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 21 | 21 | 21 |
| Reserves | -0 | 0 | 31 | 41 | 44 |
| 4 | 7 | 34 | 31 | 26 | |
| 3 | 3 | 18 | 27 | 18 | |
| Total Liabilities | 10 | 13 | 104 | 120 | 108 |
| 3 | 3 | 45 | 50 | 60 | |
| CWIP | 0 | 0 | 13 | 16 | 1 |
| Investments | 0 | 0 | 1 | 4 | 6 |
| 7 | 10 | 44 | 50 | 42 | |
| Total Assets | 10 | 13 | 104 | 120 | 108 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1 | -2 | 11 | 17 | 10 | |
| -0 | -0 | -12 | -11 | -2 | |
| -1 | 3 | 2 | -7 | -9 | |
| Net Cash Flow | 0 | 0 | 2 | -0 | -1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 99 | 103 | 72 | 107 | 72 |
| Inventory Days | 22 | 42 | 22 | 16 | 16 |
| Days Payable | 81 | 58 | 51 | 110 | 63 |
| Cash Conversion Cycle | 40 | 88 | 44 | 13 | 25 |
| Working Capital Days | 72 | 119 | -0 | 2 | 10 |
| ROCE % | 15% | 18% | 4% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count ・Standalone data |
|
|||||||||||
| Actual Production - MCA (Naroda Facility) MT ・Standalone data |
||||||||||||
| Actual Production - SMCA (Naroda Facility) MT ・Standalone data |
||||||||||||
| Capacity Utilization - MCA (Naroda Facility) % ・Standalone data |
||||||||||||
| Capacity Utilization - SMCA (Naroda Facility) % ・Standalone data |
||||||||||||
| Installed Capacity - MCA (Naroda Facility) MT ・Standalone data |
||||||||||||
| Installed Capacity - SMCA (Naroda Facility) MT ・Standalone data |
||||||||||||
| Combined Installed Capacity MTPA ・Standalone data |
||||||||||||
Documents
Announcements
-
Annuocement Under Regulation 30
21 Feb - Board and Audit Committee approved purchase of Bhavnagar land from promoter/director Kandarp Amin on Feb 21, 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
9 Feb - Newspaper advertisement - published for the financial result pertaining to quarter and nine months ended on 31st December, 2025 in Western Time (English and Gujarati) …
- Approval Of Unaudited Financial Result For The Quarter And Nine Months Ended 31.12.2025 7 Feb
-
Board Meeting Outcome for Approval Of Unaudited Financial Result Of The Company For The Quarter And Nine Month Ended December 31 2025
7 Feb - Approved unaudited results to Dec 31, 2025: Q3 revenue Rs3,930.05 lakh; Q3 net profit Rs243.48 lakh.
-
Board Meeting Intimation for Prior Intimation Of Board Meeting To Consider And Approve The Unaudited Financial Result For The Quarter Ended 31.12.2025
3 Feb - Board meeting on Feb 7, 2026 to approve unaudited results for quarter ended Dec 31, 2025; trading window closed.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
AOL manufactures a variety of Organic Chemicals, Pigments, Specialty Derivatives, Adhesives, and sealants viz. mono chloroacetic acid, sodium chloroacetate that is used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals, and plastic additives, etc.
It also entered into the Adhesives & Sealants segment by the brand AOL which offers various range of Sealants